Back to today’s briefing

Story perspectives

FDA Vaccine Chief's Stricter Rules Send Stocks Plummeting

5/8/2025

50 7

Summary

Story summary

Dr. Vinay Prasad's controversial appointment as head of the FDA’s vaccine division has sent shockwaves through the market, with vaccine stocks taking a nosedive. As he implements stricter approval requirements, fears mount over the implications for public health and the pharmaceutical industry, leaving stakeholders anxious about the future of vaccine trust and development.

1 of 1

Story summary

Dr. Vinay Prasad's controversial appointment as head of the FDA’s vaccine division has sent shockwaves through the market, with vaccine stocks taking a nosedive. As he implements stricter approval requirements, fears mount over the implications for public health and the pharmaceutical industry, leaving stakeholders anxious about the future of vaccine trust and development.